Rational Use of Antibiotics in Children with Diabetic Ketoacidosis Needs Attention
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Diabetic ketoacidosis (DKA) in children may lead to acute kidney injury (AKI). Among 45 children with DKA in our center, eight cases had AKI on admission, and in one child, his kidney function did not recover until 3 mo after discharge. This child was treated with antibiotics (cephalosporin), and we cannot rule out delayed AKI recovery due to the combined effects of the drug and the disease. Pediatricians should be concerned about the impact of nephrotoxic drug and disease interactions on children's kidney function, and need to follow up children with DKA and AKI to determine the development of AKI.
References
1.
Yang F, Tong X, McCarver D, Hines R, Beard D
. Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model. J Pharmacokinet Pharmacodyn. 2006; 33(4):485-518.
DOI: 10.1007/s10928-006-9018-0.
View
2.
Maharaj A, Edginton A
. Physiologically based pharmacokinetic modeling and simulation in pediatric drug development. CPT Pharmacometrics Syst Pharmacol. 2014; 3:e150.
PMC: 4260000.
DOI: 10.1038/psp.2014.45.
View
3.
Emoto C, Fukuda T, Johnson T, Adams D, Vinks A
. Development of a Pediatric Physiologically Based Pharmacokinetic Model for Sirolimus: Applying Principles of Growth and Maturation in Neonates and Infants. CPT Pharmacometrics Syst Pharmacol. 2015; 4(2):e17.
PMC: 4360665.
DOI: 10.1002/psp4.17.
View
4.
De Rose D, Cairoli S, Dionisi M, Santisi A, Massenzi L, Goffredo B
. Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age. Int J Mol Sci. 2020; 21(16).
PMC: 7460644.
DOI: 10.3390/ijms21165898.
View